Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: Anti-atherogenic actions of bilirubin and carbon monoxide?

Cardiovascular Research

Volumn 41, Issue 2, 1999, Pages 385-394

  Siow, Richard C M ^a   Sato, Hideyo ^a   Mann, Giovanni E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antioxidant; Atherosclerosis; Carbon monoxide; Endothelium; Heme oxygenase; Nitric oxide; Oxidative stress protein; Vascular smooth muscle

Indexed keywords

BILIRUBIN; CARBON MONOXIDE; HEME OXYGENASE; OXIDOREDUCTASE;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; ENZYME ACTIVITY; ENZYME INDUCTION; GENE TRANSFER; LIPOPROTEIN METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE TONE; THROMBOCYTE AGGREGATION; VASCULAR SMOOTH MUSCLE;

ARTERIOSCLEROSIS; BILIRUBIN; CARBON MONOXIDE; ENDOTHELIUM, VASCULAR; HEME OXYGENASE (DECYCLIZING); HUMANS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 0033026857     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00278-8     Document Type: Review

References (110)

1. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis. 23:1993;118-126.
2. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 272:1997;20963-20966.
3. Ares M., Kallin B., Eriksson P., Nilsson J. Oxidized LDL induces transcription factor activator protein-1 but inhibits activation of nuclear factor-kappa-B in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 15:1995;1584-1590.
4. Zhu Y., Lin J.H.C., Liao H.L.et al. LDL induces transcription factor activator protein-1 in human endothelial cells. Arterioscler Thromb Vasc Biol. 18:1998;473-480.
5. Holvoet P., Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 15:1994;1279-1284.
6. Sen C., Packer L. Antioxidant and redox regulation of gene-transcription. FASEB J. 10:1996;709-720.
7. Wang L.J., Lee T.S., Lee F.Y., Pai R.C., Chau L.Y. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol. 152:1998;711-720.
8. Ishikawa K., Navab M., Leitinger N., Fogelman A.M., Lusis A.J. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest. 100:1997;1209-1216.
9. Siow R.C., Ishii T., Sato H.et al. Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidised LDL in cultured vascular smooth muscle cells. FEBS Lett. 368:1995;239-242.
10. Marks G., Brien J., Nakatsu K., McLaughlin B. Does carbon monoxide have a physiological function? Trend Pharmacol Sci. 12:1991;185-188.
11. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 37:1997;517-554.
12. Cox D.A., Cohen M.L. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: Clinical and pharmacological implications in atherosclerosis. Pharmacol Rev. 48:1996;3-19.
13. Jay M.T., Chirico S., Siow R.C.M.et al. Modulation of vascular tone by low density lipoproteins: Effects on L-arginine transport and nitric oxide synthesis. Exp Physiol. 82:1997;349-360.
14. Padmanaban G., Venkateswar V., Rangarajan P. Haem as a multifunctional regulator. Trend Biol Sci. 14:1989;492-496.
15. McCoubrey W.K., Huang T.J., Maines M.D. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem. 247:1997;725-732.
16. Choi A.M.K., Alam J. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol. 15:1996;9-19.
17. Sun Y., Oberley L. Redox regulation of transcriptional activators. Free Rad Biol Med. 21:1996;335-348.
18. Terry C.M., Clikeman J.A., Hoidal J.R., Callahan K.S. Effect of tumor necrosis factor α and interleukin-1 α on heme oxygenase-1 expression in human endothelial cells. Am J Physiol. 274:1998;H883-91.
19. Prestera T., Talalay P., Alam J., Ahn Y.I., Lee P.J., Choi A.M. Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE). Mol Med. 1:1995;827-837.
20. Jornot L., Junod A.F. Variable glutathione levels and expression of antioxidant enzymes in human endothelial cells. Am J Physiol. 264:1993;L482-9.
21. Lavrovsky Y., Schwartzman M., Levere R., Kappas A., Abraham N. Identification of binding-sites for transcription factors NF-κB and AP-2 in the promoter region of the human heme oxygenase-1 gene. Proc Natl Acad Sci USA. 91:1994;5987-5991.
22. Brand K., Page S., Walli A.K., Neumeier D., Baeuerle P.A. Role of nuclear factor-κB in atherogenesis. Exp Physiol. 82:1997;297-304.
23. Maziere C., DjavaheriMergny M., FreyFressart V., Delattre J., Maziere J.C. Copper and cell- oxidized low-density lipoprotein induces activator protein 1 in fibroblasts, endothelial and smooth muscle cells. FEBS Lett. 409:1997;351-356.
24. Liao F., Andalibi A., Debeer F., Fogelman A.M., Lusis A.J. Genetic control of inflammatory gene induction and NF-κB like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest. 91:1993;2572-2579.
25. Raju V.S., McCoubrey W.K. Jr., Maines M.D. Regulation of heme oxygenase-2 by glucocorticoids in neonatal rat brain: Characterization of a functional glucocorticoid response element. Biochim Biophys Acta. 1351:1997;89-104.
26. Zakhary R., Gaine S.P., Dinerman J.L., Ruat M., Flavahan N.A., Snyder S.H. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci USA. 93:1996;795-798.
27. Yu B.P. Cellular defences against damage from reactive oxygen species. Physiol Rev. 74:1994;139-162.
28. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem. 269:1994;9397-9400.
29. Siow R.C.M., Sato H., Bannai S., Leake D.S., Pearson J.D., Mann G.E. Vitamin C protects human arterial smooth muscle cells against atherogenic lipoproteins: Effects of antioxidant vitamins on oxidized LDL-induced increases in cystine transport and glutathione. Arterioscler Thromb Vasc Biol. 18:1998;1662-1670.
30. Ghigo D., Alessio P., Foco A.et al. Nitric oxide synthesis is impaired in glutathione depleted human umbilical vein endothelial cells. Am J Physiol. 256:1993;C728-C732.
31. BasuModak S., Luscher P., Tyrrell R.M. Lipid metabolite involvement in the activation of the human heme oxygenase-1 gene. Free Rad Biol Med. 20:1996;887-897.
32. Lapenna D., de Gioia S., Ciofani G.et al. Glutathione-related antioxidant defences in human atherosclerotic plaques. Circulation. 97:1998;1930-1934.
33. Vigne P., Feolde E., Ladoux A., Duval D., Frelin C. Contributions of NO synthase and heme oxygenase to cGMP formation by cytokine and hemin treated brain capillary endothelial cells. Biochem Biophys Res Commun. 214:1995;1-5.
34. Foresti R., Clark J.E., Green C.J., Motterlini R. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of superoxide and peroxynitrite anions. J Biol Chem. 272:1997;18411-18417.
35. Morita T., Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest. 96:1995;2676-2682.
36. Morita T., Mitsialis S.A., Koike H., Liu Y.X., Kourembanas S. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem. 272:1997;32804-32809.
37. Morita T., Perrella M.A., Lee M.E., Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA. 92:1995;1475-1479.
38. Siow R.C.M., Mann G.E. Vitamin C attenuates induction of heme oxygenase-1 by oxidized LDL in human smooth muscle cells. J Physiol. 506P:1998;37P.
39. Durante W., Kroll M.H., Christodoulides N., Peyton K.J., Schafer A.I. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res. 80:1997;557-564.
40. Yet S.F., Pellacani A., Patterson C.et al. Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem. 272:1997;4295-4301.
41. Ishizaka N., DeLeon H., Laursen J.B.et al. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation. 96:1997;1923-1929.
42. Hartsfield C.L., Alam J., Cook J.L., Choi A.M. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. Am J Physiol. 273:1997;L980-L988.
43. Paganga G., Riceevans C., Rule R., Leake D. The interaction between ruptured erythrocytes and low-density lipoproteins. FEBS Lett. 303:1992;154-158.
44. Balla G., Jacob H.S., Eaton J.W., Belcher J.D., Vercellotti G.M. Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb. 11:1991;1700-1711.
45. Balla J., Nath K.A., Balla G., Juckett M.B., Jacob H.S., Vercellotti G.M. Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol. 268:1995;L321-L327.
46. Pang J., Jiang M., Chen Y.et al. Increased ferritin gene-expression in atherosclerotic lesions. J Clin Invest. 97:1996;2204-2212.
47. Balla G., Jacob H.S., Balla J., Rosenberg M.et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem. 267:1992;18148-18153.
48. Ishii T., Yamada M., Sato H.et al. Cloning and characterization of a 23 kDa stress induced mouse peritoneal macrophage protein. J Biol Chem. 268:1993;18633-18636.
49. Immenschuh S., Iwahara S., Satoh H., Nell C., Katz N., MullerEberhard U. Expression of the messenger RNA of heme-binding protein-23 is coordinated with that of heme oxygenase-1 by heme and heavy-metals in primary rat hepatocytes and hepatoma-cells. Biochem. 34:1995;13407-13411.
50. Chae H.Z., Robison K., Poole L.B., Church G., Storz G., Rhee S.G. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: Alkyl hydroperoxide reductase and thiol- specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci USA. 91:1994;7017-7021.
51. Schmidt H.H.H.W., Lohmann S.M., Walter U. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta. 1178:1993;153-175.
52. Furchgott R.F., Jothianahdan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: Relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels. 28:1991;52-61.
53. Levere R.D., Martasek P., Escalante B., Schwartzman M.L., Abraham N.G. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest. 86:1990;213-219.
54. Johnson R.A., Lavesa M., Askari B., Abraham N.G., Nasjletti A. A heme oxygenase product, presumably carbon-monoxide, mediates a vasodepressor function in rats. Hypertension. 25:1995;166-169.
55. Johnson R.A., Lavesa M., DeSeyn K., Scholer M.J., Nasjletti A. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol. 271:1996;H1132-H1138.
56. Seki T., Naruse M., Naruse K.et al. Roles of heme oxygenase carbon monoxide system in genetically hypertensive rats. Biochem Biophys Res Commun. 241:1997;574-578.
57. Suematsu M., Goda N., Sano T.et al. Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest. 96:1995;2431-2437.
58. Goda N., Suzuki K., Naito M.et al. Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation. J Clin Invest. 101:1998;604-612.
59. Grundemar L., Ny L. Pitfalls using metalloporphyrins in carbon monoxide research. Trend Pharmacol Sci. 18:1997;193-195.
60. Wang R., Wu L.Y. The chemical modification of K-Ca channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem. 272:1997;8222-8226.
61. Quast U., Guillon J., Cavero I. Cellular pharmacology of potassium channel openers in vascular smooth-muscle. Cardiovasc Res. 28:1994;805-810.
62. Weisser B., Locher R., Mengden T., Vetter W. Oxidation of low density lipoprotein enhances its potential to increase intracellular calcium concentration in vascular smooth muscle cells. Arterioscler Thromb. 12:1992;231-236.
63. Motterlini R., Foresti R., Intaglietta M., Winslow R.M. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol. 270:1996;H107-14.
64. Weiss G., Wernerfelmayer G., Werner E., Grunewald K., Wachter H., Hentze M. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J Exp Med. 180:1994;969-976.
65. Darley-Usmar V., White R. Disruption of vascular signalling by the reaction of nitric oxide with superoxide: Implications for cardiovascular disease. Exp Physiol. 82:1997;305-316.
66. Buttery L., Springall D., Chester A.et al. Inducible nitric-oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 75:1996;77-85.
67. Luoma J.S., Stralin P., Marklund S.L., Hiltunen T.P., Sarkioja T., Yla-Herttuala S. Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions. Colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol. 18:1998;157-161.
68. Awolesi M., Sessa W., Sumpio B. Cyclic strain up-regulates nitric-oxide synthase in cultured bovine aortic endothelial-cells. J Clin Invest. 96:1995;1449-1454.
69. Wagner C., Durante W., Christodoulides N., Hellums J., Schafer A. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest. 100:1997;589-596.
70. Santilli S.M., Fiegel V.D., Knighton D.R. Changes in the aortic wall oxygen tensions of hypertensive rabbits. Hypertension and aortic wall oxygen. Hypertension. 19:1992;33-39.
71. Barker S., Talbert A., Cottam S., Baskerville P., Martin J. Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Arterioscler Thromb. 13:1993;70-77.
72. Maulik N., Sharma H.S., Das D.K. Induction of the haem oxygenase gene expression during the reperfusion of ischemic rat myocardium. J Mol Cell Cardiol. 28:1996;1261-1270.
73. Sharma H.S., Maulik N., Gho B.C., Das D.K., Verdouw P.D. Coordinated expression of heme oxygenase-1 and ubiquitin in the porcine heart subjected to ischemia and reperfusion. Mol Cell Biochem. 157:1996;111-116.
74. Kourembanas S., Morita T., Liu Y., Christou H. Mechanisms by which oxygen regulates gene expression and cell-cell interaction in the vasculature. Kidney Int. 51:1997;438-443.
75. Lee P.J., Jiang B.H., Chin B.Y.et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem. 272:1997;5375-5381.
76. Wang G.L., Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 270:1995;1230-1237.
77. Koong A., Chen E., Giaccia A. Hypoxia causes the activation of nuclear factor-κB through the phosphorylation of i-κB-α on tyrosine residues. Cancer Res. 54:1994;1425-1430.
78. Kvietikova I., Wenger R.H., Marti H.H., Gassmann M. The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive. Kidney Int. 51:1997;564-566.
79. Durante W., Christodoulides N., Cheng K., Peyton K.J., Sunahara R.K., Schafer A.I. cAMP induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle. Am J Physiol. 273:1997;H317-23.
80. Imai T., Hirata Y., Kanno K., Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth-muscle cells. J Clin Invest. 93:1994;543-549.
81. McQuillan L., Leung G., Marsden P., Kostyk S., Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol. 36:1994;H1921-H1927.
82. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:1993;801-809.
83. Madhavan M., Wattigney W.A., Srinivasan S.R., Berenson G.S. Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis. 131:1997;107-113.
84. Schwertner H.A., Jackson W.G., Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 40:1994;18-23.
85. Hopkins P.N., Wu L.L., Hunt S.C., James B.C., Vincent G.M., Williams R.R. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 16:1996;250-255.
86. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. Bilirubin is an antioxidant of possible physiological importance. Science. 235:1987;1043-1046.
87. Neuzil J., Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 269:1994;16712-16719.
88. Yamaguchi T., Horio F., Hashizume T.et al. Bilirubin is oxidized in rats treated with endotoxin and acts as a physiological antioxidant synergistically with ascorbic acid in vivo. Biochem Biophys Res Commun. 214:1995;11-19.
89. Amit Y., Boneh A. Bilirubin inhibits protein kinase C activity and protein kinase C-mediated phosphorylation of endogenous substrates in human skin fibroblasts. Clin Chim Acta. 223:1993;103-111.
90. MietusSnyder M., Friera A., Glass C.K., Pitas R.E. Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C-A role for oxidative stress. Arterioscler Thromb Vasc Biol. 17:1997;969-978.
91. Rice-Evans C., Leake D., Bruckdorfer R., Diplock A.T. Practical approaches to low density lipoprotein oxidation: Whys, wherefores and pitfalls. Free Rad Res. 25:1996;285-311.
92. Abraham N.G., Lavrovsky Y., Schwartzman M.L.et al. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci USA. 92:1995;6798-6802.
93. Deramaudt B.M., Braunstein S., Remy P., Abraham N.G. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem. 68:1998;121-127.
94. Lee P., Alam J., Wiegand G., Choi A. Overexpression of heme oxygenase-1 in human pulmonary epithelial-cells results in cell-growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci USA. 93:1996;10393-10398.
95. Dennery P., Sridhar K., Lee C.et al. Heme oxygenase-mediated resistance to oxygen toxicity in hamster fibroblasts. J Biol Chem. 272:1997;14937-14942.
96. Willis D., Moore A.R., Frederick R., Willoughby D.A. Heme oxygenase: A novel target for the modulation of the inflammatory response. Nature Med. 2:1996;87-90.
97. Ishikawa K., Wang X.P., Qiao J.H., Navab M., Fogelman A.M., Lusis A.J. Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL receptor knockout mice. Circulation. 8SS:1997;619.
98. Dennery P.A., Spitz D.R., Yang G.et al. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J Clin Invest. 101:1998;1001-1011.
99. Suematsu M., Wakabayashi Y., Ishimura Y. Gaseous monoxides: a new class of microvascular regulator in the liver. Cardiovasc Res. 32:1996;679-686.
100. Motterlini R., Foresti R., Vandegriff K., Intaglietta M., Winslow R.M. Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am J Physiol. 269:1995;H648-55.
101. Visner G.A., Fogg S., Nick H.S. Hyperoxia-responsive proteins in rat pulmonary microvascular endothelial cells. Am J Physiol. 270:1996;L517-25.
102. Wagener F., Feldman E., de Witte T., Abraham N. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med. 216:1997;456-463.
103. Ishizaka N., Griendling K.K. Heme oxygenase-1 is regulated by angiotensin II in rat vascular smooth muscle cells. Hypertension. 29:1997;790-795.
104. Agarwal A., Balla J., Balla G., Croatt A., Vercellotti G., Nath K. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol. 271:1996;F814-F823.
105. Grozdanovic Z., Gossrau R. Expression of heme oxygenase-2 (HO-2)-like immunoreactivity in rat tissues. Acta Histochem. 98:1996;203-214.
106. Christodoulides N., Durante W., Kroll M.H., Schafer A.I. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation. 91:1995;2306-2309.
107. Soares M.P., Lin Y., Anrather J., Csizmadia E., Takigami K., Sato K., Grey S.T., Colvin R.B., Choi A.M., Poss K.D., Bach F.H. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nature Med. 4:1998;1073-1077.
108. Pannen B.H.J., Kohler N., Hole B., Bauer M., Clemens M.G., Geiger K.K. Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats. J Clin Invest. 102:1998;1220-1228.
109. Motterlini R., Gonzales A., Foresti R., Clark J.E., Green C.J., Winslow R.M. Heme oxygenase-1 derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res. 83:1998;568-577.
110. Juckett M., Zheng Y., Yuan H., Pastor T., Antholine W., Weber M., Vercellotti G. Heme and the endothelium. Effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase. J Biol Chem. 273:1998;23388-23397.